Prozac may reduce Exercise-Related low blood sugar in type 1 diabetes

NCT ID NCT01672255

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This early study tests whether the antidepressant fluoxetine (Prozac) can improve the body's nervous system response during exercise in people with type 1 diabetes. Many with diabetes avoid exercise due to fear of low blood sugar. The study includes 64 adults—half with type 1 diabetes and half healthy—who take either Prozac or a placebo for 6 weeks. Researchers measure stress hormone levels during exercise to see if Prozac helps the body respond better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fluoxetine (Prozac)
What this could lead to
If successful, this could point toward a way to help people with type 1 diabetes exercise more safely by reducing their risk of low blood sugar.
What could go wrong
This is a very early, small study with only 64 participants. It tests a theory, not a proven treatment, and results may not lead to any practical change.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOGLYCEMIA ASSOCIATED AUTONOMIC FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Maryland, Baltimore

    Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.